Indoramin-prolongation of repolarization time, a mechanism of bradycardia in man?
作者信息
Harron D W, Nicholls D P, Shanks R G
出版信息
Br J Clin Pharmacol. 1985 Feb;19(2):266-71. doi: 10.1111/j.1365-2125.1985.tb02642.x.
Abstract
The effect of indoramin, a selective alpha 1-adrenoceptor antagonist, on ECG time intervals in normal man was studied. Significant prolongation of QTc was observed after indoramin 100 mg, with no change in QRS duration. In addition, the slope of the RR/QT relationship was changed by indoramin 100 mg. These results suggest that indoramin may have Class III antiarrhythmic activity. If such activity were to affect the SA node, it may explain at least in part the observed lack of reflex tachycardia after indoramin administration.
摘要
相似文献
1
Indoramin-prolongation of repolarization time, a mechanism of bradycardia in man?
Br J Clin Pharmacol. 1985 Feb;19(2):266-71. doi: 10.1111/j.1365-2125.1985.tb02642.x.
2
Investigations into the bradycardic action of indoramin.
Arzneimittelforschung. 1985;35(1A):301-5.
3
Effect of acute and chronic indoramin administration on baroreflex function and tremor in humans.
J Cardiovasc Pharmacol. 1988 Mar;11(3):284-90. doi: 10.1097/00005344-198803000-00004.
4
Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoramin.
Br J Pharmacol. 1986 Feb;87(2):433-41. doi: 10.1111/j.1476-5381.1986.tb10834.x.
5
Recent developments in the pharmacology and pharmacokinetics of indoramin.
J Cardiovasc Pharmacol. 1986;8 Suppl 2:S16-9. doi: 10.1097/00005344-198600082-00004.
6
Experimental evidence for the antiarrhythmic action of indoramin.
J Cardiovasc Pharmacol. 1986;8 Suppl 2:S131-6. doi: 10.1097/00005344-198600082-00027.
7
Cardioregulatory properties of indoramin in the rat.
J Pharm Pharmacol. 1981 Apr;33(4):236-9. doi: 10.1111/j.2042-7158.1981.tb13765.x.
8
Investigation into mechanism of lack of reflex tachycardia in response to hypotensive action of indoramin in dogs.
J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):596-600. doi: 10.1097/00005344-198407000-00007.
9
Differential blockade of alpha-adrenoceptors by indoramin.
Br J Clin Pharmacol. 1984 Jun;17(6):719-28. doi: 10.1111/j.1365-2125.1984.tb02409.x.
10
Clinical cardiac electrophysiology of indoramin, a post-synaptic alpha blocker.
Eur Heart J. 1986 Jul;7(7):576-83. doi: 10.1093/oxfordjournals.eurheartj.a062108.
引用本文的文献
1
Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.
Drugs. 1986 Jun;31(6):467-99. doi: 10.2165/00003495-198631060-00002.
2
Effect of acute and chronic oral administration of alfuzosin on baroreflex function and tremor in man.
Br J Clin Pharmacol. 1988 Apr;25(4):417-24. doi: 10.1111/j.1365-2125.1988.tb03324.x.
本文引用的文献
1
Cardiovascular effects of indoramin in man--a dose ranging study.
Br J Clin Pharmacol. 1983 Jan;15(1):31-6. doi: 10.1111/j.1365-2125.1983.tb01459.x.
2
Drugs with a class III antiarrhythmic action.
Pharmacol Ther. 1982;17(3):315-55. doi: 10.1016/0163-7258(82)90020-1.
3
Correction equation for ECG time intervals.
Br J Clin Pharmacol. 1984 Jul;18(1):113-5. doi: 10.1111/j.1365-2125.1984.tb05036.x.
4
The QT interval and cycle length: the influence of atropine, hyoscine and exercise.
Br J Clin Pharmacol. 1983 Dec;16(6):615-21. doi: 10.1111/j.1365-2125.1983.tb02230.x.
5
Pharmacological mapping of regional effects in the rabbit heart of some new antiarrhythmic drugs.
Br J Pharmacol. 1983 Jul;79(3):701-9. doi: 10.1111/j.1476-5381.1983.tb10007.x.
6
Investigation into mechanism of lack of reflex tachycardia in response to hypotensive action of indoramin in dogs.
J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):596-600. doi: 10.1097/00005344-198407000-00007.
7
Differential blockade of alpha-adrenoceptors by indoramin.
Br J Clin Pharmacol. 1984 Jun;17(6):719-28. doi: 10.1111/j.1365-2125.1984.tb02409.x.
8
The effect of oral quinidine on intraventricular conduction in man: correlation of plasma quinidine with changes in QRS duration.
Am Heart J. 1970 Oct;80(4):453-62. doi: 10.1016/0002-8703(70)90191-2.
9
Electrophysiological basis for a rational approach to antidysrhythmic drug therapy.
Adv Drug Res. 1974;9:69-101.
10
The reversal of experimental cardiac arrhythmias by indoramin (Wy 21901).
J Pharm Pharmacol. 1971 Sep;23(9):678-86. doi: 10.1111/j.2042-7158.1971.tb08744.x.
Zotero 插件